ArticleHepatology international2026

Re-examining the incremental benefit of TACE-TKI-PD-1 triplet therapy: time-related bias and treatment pathways in a real-world HCC cohort.

Yuanqin Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.